Peptide motif analysis predicts lymphocytic choriomeningitis virus as trigger for multiple sclerosis

Molecular Immunology
Charissa Hogeboom

Abstract

The etiology of multiple sclerosis (MS) involves both genetic and environmental factors. Genetically, the strongest link is with HLA DRB1*1501, but the environmental trigger, probably a virus, remains uncertain. This investigation scans a panel of proteins from encephalitogenic viruses for peptides homologous to the primary autoantigen from myelin basic protein (MBP), then evaluates candidate peptides against a motif required for T cell cross-reactivity and compares viral prevalence patterns to epidemiological characteristics of MS. The only peptide meeting criteria for cross-reactivity with MBP was one from lymphocytic choriomeningitis virus (LCMV), a zoonotic agent. In contrast to current candidates such as Epstein-Barr virus, the distribution of LCMV is consistent with epidemiological features of MS, including concentration in the temperate zone, higher prevalence farther from the equator, and increased prevalence in proximity to regions of peak MS incidence, while lack of person-to-person transmission is consistent with low MS concordance across monozygotic twins. Further, LCMV blocks induction of type I interferon (IFN). Hypothetically this would dysregulate immune processes in favor of proinflammatory pathways as well as ...Continue Reading

References

Nov 5, 1978·Journal of Molecular Biology·J Janin, S Wodak
May 5, 1975·JAMA : the Journal of the American Medical Association·R J BiggarG E Haughie
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S Henikoff, J G Henikoff
Oct 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·D H MillerD C Skegg
Sep 2, 1985·FEBS Letters·G W WellingS Welling-Wester
Feb 1, 1988·Brain : a Journal of Neurology·S R HammondM G McCall
Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D EisenbergT C Terwilliger
Jan 1, 1994·Neurology·C J MumfordD A Compston
May 4, 2001·Journal of Autoimmunity·R S Fujinami
Jul 20, 2002·Clinical Neurology and Neurosurgery·Eris Materljan, Juraj Sepcic
Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·C J WillerUNKNOWN Canadian Collaborative Study Group
Oct 22, 2005·Annals of Neurology·Giovanni RistoriMarco Salvetti
May 11, 2006·Annals of Neurology·Talat IslamThomas M Mack
Jun 30, 2006·Journal of the Neurological Sciences·Borut PeterlinMiljenko Kapović
Jul 14, 2006·Genes and Immunity·L G M van BaarsenC L Verweij
Jun 9, 2007·Annals of Neurology·Daniel J BonthiusPaul D Larsen
Aug 30, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H KuusistoI Elovaara
Jul 25, 2009·Emerging Infectious Diseases·Valentina TagliapietraAnnapaola Rizzoli
Sep 15, 2009·Veterinary Microbiology·R N Charrel, X de Lamballerie
Jul 6, 2010·Biochimica Et Biophysica Acta·Kristina KakalachevaJan D Lünemann
Nov 11, 2010·Arthritis Research & Therapy·Tineke CantaertLisa G M van Baarsen
Dec 24, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Wei QiuAllan G Kermode
Feb 11, 2011·Seminars in Immunology·Kai W Wucherpfennig, Dhruv Sethi
Apr 12, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·Steve SimpsonBruce Taylor
Jun 10, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Eleonora CoccoMaria G Marrosu
May 12, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Elizabeth M VisserCarl E Counsell
Jun 26, 2012·Immunological Reviews·Pierre-Antoine GourraudSergio E Baranzini
Feb 24, 2015·Pharmacological Reviews·Stefan SiebertIain McInnes

❮ Previous
Next ❯

Citations

May 26, 2017·Acta Neurologica Scandinavica·A-F A MentisG M Hadjigeorgiou
Dec 25, 2019·Proceedings of the National Academy of Sciences of the United States of America·Pravitt GourhElaine F Remmers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.